Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
ALX Oncology Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
Expect to report safety and early efficacy data from the Phase 1 dose-escalation study of ALX2004 in EGFR-expressing solid tumors and plan to host a KOL webinar to review the results in December 2026 Topline data from 120 patients in Phase 2...
Galectin Therapeutics Reports September 30, 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
NORCROSS, Ga., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months...
Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
IND application for NMRA-215 (NLRP3 inhibitor) submitted to the U.S. Food and Drug Administration Dose-proportional increase in exposure observed in multiple ascending dose (MAD) expansion cohort with NMRA-511 (V1aR antagonist), suggesting...
Apnimed Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
New Drug Application (“NDA”) for AD109, with a proposed proprietary name Oxnimbi™ (aroxybutynin and atomoxetine) tablets, for oral use, remains under U.S. Food and Drug Administration (“FDA”) review with a February 28, 2027, Prescription Drug User...
Beyond Oil Reports Third Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
Record Quarterly Revenue of US$1.4 Million, Up 22% Year-over-Year; Eighth Consecutive Quarter of Sequential Growth; Operating Expenses Down 11% from Q2 System-Wide and Global Vendor Approvals, New Chain Adoptions and First Industrial Adoption...
HCW Biologics Reports Third Quarter 2026 Business and Clinical Development Highlights and Financial Results
GlobeNewswire, Inc.
MIRAMAR, Fla., Nov. 16, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion immunotherapeutics to treat autoimmune...
Rein Therapeutics Announces Preliminary Blinded Phase 2 RENEW Data Showing Encouraging Lung Function Trends in Patients with Idiopathic Pulmonary Fibrosis and Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
33% of evaluable patients demonstrated improvement over baseline in forced vital capacity (FVC) at Week 12 From baseline, change in FVC ranged from an improvement of 338 ml to a decline of 349 ml at Week 12 Low discontinuation rates, and favorable...
Cerenome Reports Interim ReSPECT-LM Data Supporting Repeat Dosing of REYOBIQ™ in Leptomeningeal Metastases at the 2026 SNO Annual Meeting
GlobeNewswire, Inc.
HOUSTON, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted radiopharmaceuticals, and artificial...
NervGen Reports Third Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire, Inc.
Company plans to request a multidisciplinary Type B meeting with FDA to discuss NVG-291’s continued development and opportunities to expedite the program following Breakthrough Therapy designation Enrollment ongoing in the Phase 3 RESTORE study,...
Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
DECLARATION Phase 3 clinical trial data on VYD2311 (ibramvibart) to be available imminently, per the Accelerated Approval analysis and regulatory submission plan previously communicated Updated data timing driven by dialogue between Invivyd and...
GT Biopharma Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with an update anticipated in Q4 2026 Phase 1 basket trial evaluating GTB-5550 TriKE® in multiple solid tumor types known to express B7-H3 remains ongoing, with an update anticipated in Q4...
Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
Enrollment of Phase 1 study of PRT13722, a first-in-class highly-selective oral KAT6A degrader in HR+ breast cancer is underway; initial proof of concept data anticipated in the 2nd half of 2027 Entered into a clinical trial collaboration and...
Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PKP2 Arrhythmogenic Cardiomyopathy and Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
Participants in high-dose cohorts achieved 80% mean reduction in non-sustained ventricular tachycardia and 44% mean reduction in premature ventricular contractions at latest assessment LX2020 generally well tolerated across 10 participants with no...
Medicenna Reports More than Doubling of Median Overall Survival in Glioblastoma Patients With Unresectable Recurrent IDH-WT Tumors Following One Treatment with Bizaxofusp Versus a Matched External Control at SNO 2026
GlobeNewswire, Inc.
Median overall survival (mOS) was 13.7 months with a single high-dose treatment with bizaxofusp vs. 6.2 months for an eligibility-matched and propensity score-balanced external control arm (ECA) in a Phase 3 relevant unresectable IDH-wildtype...
New Study Shows Beer is Brits’ Top Drink of Choice
GlobeNewswire, Inc.
Beer is Brits’ most popular choice of alcoholic drink, ahead of wine and spirits.
Helus Pharma Reports Second Quarter Fiscal 2027 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
Appointed Michael Halstead as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization Completed enrollment in the Phase 3 APPROACH pivotal study of HLP003 in major depressive disorder (“MDD”); topline data...
Investor Notice: Ensign Group (NASDAQ:ENSG) Sued for Securities Fraud after Short Seller Report on Neglect Issues Causes 8% Stock Drop – Contact BFA Law
GlobeNewswire, Inc.
NEW YORK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Ensign Group, Inc. (NASDAQ:ENSG) and certain of the company’s senior executives for...
H World Group Limited Reports Third Quarter of 2026 Unaudited Financial Results
GlobeNewswire, Inc.
A total of 14,026 hotels or 1,381,324 hotel rooms were in operation as of September 30, 2026. Hotel turnover1 increased 11.3% year-over-year to RMB34.0 billion in the third quarter of 2026. By segments, hotel turnover from the H World China...
Compliance-First Engineering, OEM/ODM Dual Track:Jinchang Builds Food Steamer Brand Moat with CE/LFGB/CB Certified SC750
EIN Presswire
Founded in 1996, operating a 5,500m² own plant in Yuyao, Zhejiang, with ~68 employees and annual capacity of 1.2 million units, a National High-Tech Enterprise.
Comprehensive Report on the Carbon Black for Packaging Market Includes Forecasts, Innovations, and Industry Insights
EIN Presswire
The Business Research Company's Comprehensive Report on the Carbon Black for Packaging Market Includes Forecasts, Innovations, and Industry Insights LONDON, GREATER LONDON, UNITED KINGDOM, November 16, 2026 /EINPresswire.com/ -- "The carbon...
Sign up for:
Food & Beverage Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.